Endeavor

Can a Ketogenic Diet Boost Effectiveness of Cancer Immunotherapy?

Study finds that a compound from ketosis helps fuel the CAR T cells, making them more effective at attacking cancer

New CAR T-Cell Therapy Shows Promising Results for Advanced Multiple Myeloma

Early trial results show high success rates and manageable side effects

Moffitt Study Explores Key Risk Factors To Better Personalize CAR T-Cell Therapy

The study analyzed ide-cel to help physicians intervene and reduce toxicities in multiple myeloma patients

Largest Comprehensive Study Compares Efficacy of CAR T Products for Multiple Myeloma

Cilta-cel demonstrates greater effectiveness than ide-cel but carries higher toxicities, study finds

Moffitt Patient Is First To Receive Second CAR T Therapy for Ovarian Cancer

Patient receives second dose of CAR-T immunotherapy for ovarian cancer with special approval from the FDA.

Newly Approved CAR T-Cell Therapy Gives Acute Lymphoblastic Leukemia a New Personalized Option

Novel design and tumor-guided dosing may reduce side effects while maintaining encouraging efficacy

Moffitt Hosts Inaugural Cell Coast Conference to Spotlight Breakthroughs in Cellular Immunotherapy

Experts discuss the latest advances in CAR T, TIL and TCR therapies

Moffitt Patients Meet Donors at Transplant Reunion

This event celebrated survivorship and coincided with the 35th anniversary of Moffitt's Blood and Marrow Transplant and Cellular Immunotherapy Department

Radiation Therapy May Boost Effectiveness of CAR T-Cell Treatment in Aggressive Multiple Myeloma

Moffitt study highlights the potential for improved outcomes by targeting extramedullary disease before cell therapy